Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
AERIShowing 0 of 14 quarters
Position history for Bank of New York Mellon Corp's holdings in AERIE PHARMACEUTICALS INC
As of its Q3 2022 13F, Bank of New York Mellon held 238,464 shares of AERI (Aerie Pharmaceuticals), worth $3.6M. Bank of New York Mellon's 13F filings listed AERI from Q3 2019 to Q3 2022, 13 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of AERI: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.